Page 14

Note from the MBC’s Executive Director: For the past three years, the Medical Board of California (Board) has made it a priority to address the epidemic of deaths related to overprescribing and misuse of controlled substances. The Board held a Joint Forum with the State Board of Pharmacy, initiated a Prescribing Task Force that was instrumental in revision of the Board’s Guidelines for Prescribing Controlled Substances for Pain (Guidelines) released in November 2014, produced public service announcements (PSAs) for both the public and physicians about the importance of safe prescribing and opioid use, and took enforcement actions against physicians who departed from the standard of care when prescribing opioids to patients. The Legislature also believes this issue is important and passed legislation that requires any physician who is authorized to prescribe, order, administer, furnish, or dispense Schedules II, III, or IV controlled substances to be registered with CURES (Controlled Substance Utilization Review and Evaluation System) by July 1, 2016.

14 | THE BULLETIN | MAY / JUNE 2016

Profile for SCCMA/MCMS

2016 May/June  

2016 May/June  

Profile for 18621